Molecular testing in lung cancer explained in 1 slide by a thoracic pathologist
What molecular tests are needed in lung cancer? Which tumors need to be tested? How is the testing done? This video attempt to explain these and other questi…
What molecular tests are needed in lung cancer? Which tumors need to be tested? How is the testing done? This video attempt to explain these and other questi…
Artificial intelligence is on the move as machine learning getโs better and better as we speak: Listen to the newest developments in @InsideCardiology Cardi…
THURSDAY, Feb. 13, 2025 (HealthDay News) — You may be less likely to develop an especially lethal form of colon cancer if you’re a longtime…
Join Jesse Michels on today’s episode of American Alchemy as he sits down with Dave Rossi. Dave was a blue-collar construction worker until a life-altering…
Jordan Peterson sits down with bestselling author and bioenergetics Ph.D., Dr. Benjamin Bikman. They discuss the epidemic of insulin resistance in America an…
Advancements in comprehending myelodysplastic neoplasms (MDS) have unfolded significantly in recent years, elucidating a myriad of cellular and molecular underpinnings integral to disease progression…
Share your videos with friends, family, and the world
Mool mantraIk Onkaar(There is one God)Sat Naam(Whose name is Truth)Kartaa Purakh(Is the creator)Nirbh-a-o Nirvair(Has no fear, Has no hate)Akaal Moorat(Is om…
Maternal platelet-activating antiโplatelet factor 4 antibodies led to cerebral venous sinus thrombosis, thrombocytopenia, hyperfibrinolysis, and cerebral bleeding in a neonate.
Shankar Siva: TFS at 1 year is approximately 90% with SABR / cancer, Daniel Heng, OncoDaily, Oncology, SABR, Shankar Siva
CME Symposium Series | March 15-16, 2025, Seattle, Washington All events are complimentary. Both sessions will take place at the Seattle Convention Center 705 Pike…